×÷ΪÖйúµÚÈý·½¼ì²âÓëÈÏÖ¤·þÎñµÄ¿ªÍØÕߺÍÁìÏÈÕߣ¬CTI9888À˹ά¼Ó˹¼ì²âΪȫÇò¿Í»§ÌṩһվʽĥÁ·¡¢²âÊÔ¡¢Ð£×¼¡¢ÈÏÖ¤¼°ÊÖÒÕ·þÎñ¡£
·þÎñÄÜÁ¦ÒÑÖÜÈ«ÁýÕÖµ½·ÄÖ¯´ò°ç¼°Ð¬°ü¡¢Ó¤Í¯Íæ¾ß¼°¼Ò¾ÓÉúÑÄ¡¢µç×ÓµçÆ÷¡¢Ò½Ñ§¿µ½¡¡¢Ê³Îï¼°Å©²úÆ·……µÈÐÐÒµµÄ¹©Ó¦Á´ÉÏÏÂÓΡ£
ÖÜÈ«°ü¹ÜÆ·ÖÊÓëÇå¾²£¬Íƶ¯ºÏ¹æÓëÁ¢Ò죬ÕÃÏÔÆ·ÅƾºÕùÁ¦£¬ÊµÏÖ¸ü¸ßÖÊÁ¿¡¢¸ü¿µ½¡¡¢¸üÇå¾²¡¢¸üÂÌÉ«µÄ¿ÉÒ»Á¬Éú³¤¡£
9888À˹ά¼Ó˹ÉúÎï¿Éƾָ֤µ¼ÔÔòÒªÇ󣬿ªÕ¹ÏµÍ³µÄÒ©´ú¶¯Á¦Ñ§Ñо¿£¬°üÀ¨ÌåÄÚÒ©´úºÍÌåÍâÒ©´ú¡£
ÌåÄÚ´úлIn vivo metabolism
1£©Ò©ÎïÎüÊÕ¡¢ÂþÑÜ¡¢´úлÓëÉøÍ¸ÌØÕ÷±íÕ÷ Absorption, distribution, metabolism and excretion(ADME)
2£©Ò©ÎïÌåÄÚÀú³Ì¼°Ö÷ÒªÒ©¶¯Ñ§²ÎÊý Intracorporal process of drugs and major PK parameter
3£©ÉúÎïʹÓöÈBioavailability
4£©ÉúÎïµÈЧÐÔBioequivalence
ÌåÍâ´úл In vitro metabolism
1£©È˺Ͷ¯ÎïµÄ´úлÎȹÌÐÔ Species variation in metabolism
2£©Ò©Îï´úлÏ໥×÷Óà Drug-drug interactions
3£©Ò©ÎïתÔËÌØÕ÷Drug absorption and kinetics
4£©Ñª½¬ÂѰ×ÍŽáProtein binding
5£©´úл²úÆ·ÆÊÎöMetabolite identification, stability, and profile
·þÎñÓÅÊÆ
²¡ÀíʵÑéÊÒ
ÌṩÇкÏGLP¹æ·¶µÄÆÊ½â¼°×éÖ¯²¡ÀíÑо¿£¬°üÀ¨Äö³ÝÀàºÍ·ÇÄö³ÝÀදÎïµÄÆÊ½â£¬×éÖ¯ÔàÆ÷µÄÈ¡²Ä¡¢°üÂñ¡¢ÇÐÆ¬¡¢Í¨ÀýȾɫ¡¢ÌØÊâȾɫ¼°ÃâÒß×éÖ¯»¯Ñ§È¾É«£¬ÖÐÓ¢ÎÄ×éÖ¯²¡ÀíѧÕï¶Ï¼°±¨¸æ
ÁÙ´²Ä¥Á·ÊÒ
ÈÏÕæ¾ÙÐж¯ÎïµÄѪҺѧ¼ì²é¡¢ÑªÉú»¯¼ì²é¡¢ÑªÄý¹¦Ð§¼ì²é¡¢¹ÇËèÐÎ̬ѧ¼ì²é¼°ÄòÒº¼ì²é¡£Ö÷ÒªÒÇÆ÷×°±¸ÓУºSiemens ADVIA 2120i¶¯ÎïÓÃÎå·ÖÀàÈ«×Ô¶¯ÑªÒºÆÊÎöÒÇ£¬Roche Cobas 6000 C501È«×Ô¶¯Éú»¯ÆÊÎöÒÇ£¬Sysmex CA-7000È«×Ô¶¯ÑªÄýÒÇ£¬AUTION MAX AX-4030ÄòÑùÆÊÎöÒÇ¡¢BD FACS CaliburÁ÷ʽϸ°ûÒÇ¡¢CHRONO-LOG 700ѪС°åȺ¼¯ÒÇ¡£
¹©ÊÔÆ·¹ÜÀíÊÒ
ÓµÓй©ÊÔÆ·¹ÜÀíÊÒ¡¢¹©ÊÔÆ·ÅäÖÆÊÒ¡¢¹©ÊÔÆ·´æ·ÅÊÒ¡£Æ¾Ö¤GLPºÍSOPµÄÒªÇó£¬ÊµÑé¶Ô¹©ÊÔÆ·¡¢±ÈÕÕÆ·¼°ÊÔÑéÏà¹ØÊÔ¼Á¡¢Ò©Æ·µÄ¹ÜÀí£¬¶Ô¹©ÊÔÆ·µÄÎüÊÕ¡¢ÉúÑÄ¡¢ÅäÖÆ¡¢ÆÊÎö¡¢·¢·Å¡¢½ÓÄɼ°¹éµµµÈ¶à¸ö»·½Ú¾ÙÐпØÖƺ͹ÜÀí¡£
ÆÊÎö²âÊÔÊÒ
ÆÊÎö²âÊÔ²¿×÷Ϊ¹«Ë¾½¹µã²¿·ÖÖ®Ò»£¬ÒÀÀµ×¨ÒµµÄ²âÊÔÍýÏë¡¢ÏȽøµÄʵÑé×°±¸(UPLC¡¢LC/MS/MS¡¢PE¶à±êλ¼ì²âÒÇ)ºÍ¶àÄêµÄÐÐÒµÁìÏÈÂÄÀú£¬ Ö÷ҪΪº£ÄÚÍâ¿Í»§Ìṩ¶¾´ú/Ò©´úÑùÆ·µÄÆÊÎö¼ì²â·þÎñ£¬²¢ÄÜÕë¶Ô¿Í»§µÄÏêϸҪÇóΪÆäÁ¿Éí¶¨×öÏàÒ˵Ľâ¾ö¼Æ»®¡£
¶¯Îï·¿
ƾ֤¹ú¼Ò±ê×¼½¨³É£¬ÓµÓÐSPF¼¶ºÍͨË×¼¶¶¯ÎïÉèÊ©ÒÔ¼°Î¢ÉúÎï¼ì²âÊÒ¡£½ÓÄÉJonson ControlsϵͳÖÇÄÜ»¯¿ØÖƶ¯ÎïÉèÊ©µÄζȡ¢Êª¶È¡¢Ñ¹²î£¬²¢ÄÜʵÏÖ¶Ô¶¯ÎïÉèÊ©¼°¸¨ÖúÉèÊ©24СʱÇå¾²¼à¿Ø¼°±¨¾¯¡£